Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SLC17A4 |
| Upstream (Parents) |
|---|
| (<<) ADH6 → SLC17A4 |
| (<<) A1CF → SLC17A4 |
| Downstream (Children) |
|---|
| SLC17A4 → FSCN2 (>>) |
| SLC17A4 → RNF128 (>>) |
| SLC17A4 → OXCT1 (>>) |
| SLC17A4 → SLC22A3 (>>) |
| SLC17A4 → NPY2R (>>) |
| SLC17A4 → CDHR5 (>>) |
| SLC17A4 → CYP2B7P1///CYP2B6 (>>) |
| SLC17A4 → UNC93A (>>) |
| SLC17A4 → CYP2B6 (>>) |
| SLC17A4 → SPINK1 (>>) |
| SLC17A4 → ADAM22 (>>) |
| SLC17A4 → CACNG5 (>>) |
| SLC17A4 → DPY19L2P2 (>>) |
